Please login to the form below

Not currently logged in


This page shows the latest Cardiome news and features for those working in and with pharma, biotech and healthcare.

Cardiome shares fall as Merck drops oral AF drug

Merck plans to launch the intravenous formulation in 30 more countries this year, according to Cardiome. ... We are extremely disappointed with the decision Merck has made," said Doug Janzen, Cardiome's president and chief executive. “

Latest news

  • MSD strikes vernakalant deal with Astellas

    In October 2003, Astellas US was granted an exclusive licence to develop and commercialise vernakalant iv in Canada, Mexico and the US by Cardiome Pharma Corp.

  • The power of small

    Rhythm Search Developments (RSD), which evolved into Nortran Pharmaceuticals and subsequently Cardiome Pharma.

  • New drug approvals point to possible blockbusters

    The list includes the cholesterol drug Cordaptive from Merck &Co, the heart medication Kynapid (vernakalant) from Cardiome Pharma and the anaesthesia-complication drug Sugammadex from Schering-Plough. ... Kynapid from Cardiome Pharma would be the first

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2013 Pharma deals during November 2013

    In a similar vein, Cardiome completed its acquisition of Correvio, a privately owned Swiss company (previously known as Iroko Cardio), achieving a European infrastructure for marketing its products. ... Cardiome has acquired Correvio through the purchase

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Merck & Co’s Jürgen Polifka joins Cardiome Merck & Co’s Jürgen Polifka joins Cardiome

    Merck &Co’ s Jürgen Polifka joins Cardiome. Will lead commercialisation in Europe of atrial fibrillation treatment Brinavess. ... Jürgen Polifka has left his role at Merck and Co to join Canada-based biopharma Cardiome as general manager, sales and

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...